Linked Life Data

12749363

Source:http://linkedlifedata.com/resource/pubmed/id/12749363

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-5-15
pubmed:abstractText
Though currently an experimental technology, there is the potential for implantation of 100,000 total artificial replacement hearts each year in the United States once regulatory approvals are obtained. Although these devices are intended to lengthen life and improve its quality, clinical scenarios can emerge in which the device is no longer serving these goals and termination of life support, including inactivation of the implant, must be contemplated. Although the literature is replete with guidance on the withdrawal of non-implantable therapies, such as dialysis and artificial ventilation, there has been minimal discussion involving the deactivation of implanted therapies. Here, guidance is offered regarding the withdrawal of total artificial heart therapy.
pubmed:commentsCorrections
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
E
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0748-1187
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
HSR
pubmed:authorsComplete
Y
pubmed:pagination
295-304
pubmed:dateRevised
2004-12-4
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Contemplating total artificial heart inactivation in cases of futility.
pubmed:affiliation
Monash University, East Bentleigh, Victoria, Australia, and Loma Linda University, Loma Linda, CA, USA. Bioethics@go.com
pubmed:publicationType
Journal Article